Skip to main content
. 2019 Aug 7;14:1789–1801. doi: 10.2147/COPD.S208081

Figure 3.

Figure 3

The effect of tiotropium/olodaterol combination therapy versus tiotropium monotherapy in time spent on 1.0–1.5 METs (A), ≥2.0 METs (B), and ≥3.0 METs (C) activity levels (change from baseline) by subgroups defined by baseline factors.

Abbreviations: BMI, body mass index; IC, inspiratory capacity; METs, metabolic equivalents; SGRQ, St George’s Respiratory Questionnaire; Tio, tiotropium; T+O, tiotropium/olodaterol.